AI Insight
The article presents chiral multimodal nanoprobes designed for the detection of biological biomarkers. These nanoprobes leverage chiroptical properties, meaning they interact differently with left- and right-handed polarized light, enabling highly sensitive and selective sensing. The multimodal nature of the probes suggests they combine several detection techniques simultaneously, improving accuracy and reliability in identifying target molecules.
Why it matters
Such nanoprobes could advance early disease diagnosis by enabling the detection of biomarkers at very low concentrations in biological samples. Their sensitivity and selectivity make them candidates for clinical applications in cancer detection, infectious disease monitoring, and personalized medicine.
Source: Chiral multimodal nanoprobes for sensing of biomarkers